761 related articles for article (PubMed ID: 25456829)
1. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
2. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
3. Liposomalized oligopeptides in cancer therapy.
Asai T; Oku N
Methods Enzymol; 2005; 391():163-76. PubMed ID: 15721380
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
[TBL] [Abstract][Full Text] [Related]
5. cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer.
Wang F; Chen Z; Zhu L
J Liposome Res; 2015; 25(2):89-100. PubMed ID: 24960451
[TBL] [Abstract][Full Text] [Related]
6. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
7. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
8. Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides.
Wu M; Huang T; Wang J; Chen P; Mi W; Ying Y; Wang H; Zhao D; Huang S
Medicine (Baltimore); 2018 Aug; 97(33):e11916. PubMed ID: 30113492
[TBL] [Abstract][Full Text] [Related]
9. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
[TBL] [Abstract][Full Text] [Related]
10. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
11. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells.
Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.
Chen Z; Deng J; Zhao Y; Tao T
Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235
[TBL] [Abstract][Full Text] [Related]
13. Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer.
Ke X; Lin W; Li X; Wang H; Xiao X; Guo Z
Drug Deliv; 2017 Nov; 24(1):1680-1689. PubMed ID: 29092646
[TBL] [Abstract][Full Text] [Related]
14. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
[TBL] [Abstract][Full Text] [Related]
15. Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).
Scherzinger-Laude K; Schönherr C; Lewrick F; Süss R; Francese G; Rössler J
Int J Nanomedicine; 2013; 8():2197-211. PubMed ID: 23818777
[TBL] [Abstract][Full Text] [Related]
16. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles.
Gao Y; Zhou Y; Zhao L; Zhang C; Li Y; Li J; Li X; Liu Y
Acta Biomater; 2015 Sep; 23():127-135. PubMed ID: 26013038
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
19. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
